Active Ingredient History
Edaravone is a free radical scavenger developed for the treatment of amyotrophic lateral sclerosis. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Stroke (approved 2010)
Alzheimer Disease (Phase 2)
Brain Diseases (Phase 2)
Brain Injuries (Phase 2)
Cerebral Hemorrhage (Phase 2)
Cerebral Infarction (Phase 4)
Drug Interactions (Phase 1)
Drugs, Investigational (Phase 3)
Edaravone (Phase 3)
Healthy Volunteers (Phase 1)
Intracranial Hemorrhages (Phase 1)
Ischemic Stroke (Phase 3)
Kidney Failure, Chronic (Phase 1)
Liver Diseases (Phase 1)
Lung Diseases (Phase 2)
Myocardial Infarction (Phase 4)
Nasopharyngeal Carcinoma (Phase 2)
Neuromuscular Diseases (Phase 1/Phase 2)
Pharmacokinetics (Phase 1)
Reperfusion Injury (Phase 4)
Scopolamine (Phase 2)
Stroke (Phase 4)
Thrombosis (Phase 3)
Treatment Outcome (Phase 3)
Vascular Diseases (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue